UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Correction: Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule

PloS one, 2012-10, Vol.7 (10)

2012

Volltextzugriff (PDF)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Oncoscience, 2014-03, Vol.1 (3), p.216-228

2014

Volltextzugriff (PDF)

Link between p53 isoforms and angiogenesis: Current prospects

South Asian journal of cancer, 2013-07, Vol.2 (3), p.108-108

Bid, Hemant

2013

Volltextzugriff (PDF)

Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia

Indian journal of urology, 2012-10, Vol.28 (4), p.377-381

2012

Volltextzugriff (PDF)

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities

Indian journal of human genetics, 2012-09, Vol.18 (3), p.274-275

2012

Volltextzugriff (PDF)

New cassane butenolide hemiketal diterpenes from the marine creeper Caesalpinia bonduc and their antiproliferative activity

Tetrahedron letters, 2007-10, Vol.48 (40), p.7194-7198

2007

Volltextzugriff (PDF)

Targeting Angiogenesis in Childhood Sarcomas

Sarcoma, 2011, Vol.2011, p.601514-10

2011

Volltextzugriff (PDF)

Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma

NPJ precision oncology, 2022-01, Vol.6 (1), p.1-1, Article 1

2022

Volltextzugriff (PDF)

Re: Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review

European urology, 2012-04, Vol.61 (4), p.846-847

Bid, Hemant Kumar

2012

Volltextzugriff (PDF)

BET bromodomain inhibitor (JQ1) and tumor angiogenesis

Oncoscience, 2016, Vol.3 (11-12), p.316-317

2016

Volltextzugriff (PDF)

Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?

Indian journal of urology, 2010-10, Vol.26 (4), p.497-501

2010

Volltextzugriff (PDF)

Abstract 5825: Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5825-5825

2017

Volltextzugriff (PDF)

Abstract 49: Modulating insulin receptor splicing as a potential therapeutic approach for rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.49-49

2017

Volltextzugriff (PDF)

Mitochondrial‐Targeted Antioxidant Treatment in a Mouse Model of Non‐Alcoholic Fatty Liver Disease

The FASEB journal, 2015-04, Vol.29 (S1)

2015

Volltextzugriff (PDF)

Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

Clinical cancer research, 2022-01, Vol.28 (2), p.431-431

2022

Volltextzugriff (PDF)

Abstract 2472: Mechanisms of resistance to IGFR-targeted therapy in pediatric sarcomas

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2472-2472

2016

Volltextzugriff (PDF)

Abstract 286: Preclinical study: HDAC inhibition combined with gemcitabine for the treatment of leiomyosarcoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.286-286

2016

Volltextzugriff (PDF)

Abstract LB-014: Targeting insulin receptor splicing as a therapeutic intervention for pediatric rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-014-LB-014

2016

Volltextzugriff (PDF)

ET-59DEVELOPMENT AND CHARACTERIZATION OF A MEK1 INHIBITOR (AZD6244) SENSITIVE CHILDHOOD ASTROCYTOMA CELL LINE

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v92-v92

2014

Volltextzugriff (PDF)

Abstract B40: Autocrine and paracrine IL-6 and IL-8 drive osteosarcoma lung tropism and facilitate metastasis

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5_Supplement), p.B40-B40

2016

Volltextzugriff (PDF)

Abstract A45: Autocrine and paracrine IL-6 and IL-8 drive osteosarcoma metastasis

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20_Supplement), p.A45-A45

2014

Volltextzugriff (PDF)

Abstract 25: Targeting c-Myc in pediatric sarcoma xenografts with the BET bromodomain inhibitor, JQ1, disrupts angiogenesis

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.25-25

2014

Volltextzugriff (PDF)

Abstract 2775: Development and characterization of a MEK1 inhibitor (AZD6244) sensitive childhood astrocytoma cell line

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2775-2775

2014

Volltextzugriff (PDF)

Corrigendum to “Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents” [Bioorg. Med. Chem. 19 (2011) 5409–5419]

Bioorganic & medicinal chemistry, 2019-09, Vol.27 (17), p.3960-3961

2019

Volltextzugriff (PDF)

ET-59 DEVELOPMENT AND CHARACTERIZATION OF A MEK1 INHIBITOR (AZD6244) SENSITIVE CHILDHOOD ASTROCYTOMA CELL LINE

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v92-v92

2014

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correction: Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Link between p53 isoforms and angiogenesis: Current prospects

Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities

New cassane butenolide hemiketal diterpenes from the marine creeper Caesalpinia bonduc and their antiproliferative activity

Targeting Angiogenesis in Childhood Sarcomas

Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma

Re: Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review

BET bromodomain inhibitor (JQ1) and tumor angiogenesis

Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?

Abstract 5825: Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines

Abstract 49: Modulating insulin receptor splicing as a potential therapeutic approach for rhabdomyosarcoma

Mitochondrial‐Targeted Antioxidant Treatment in a Mouse Model of Non‐Alcoholic Fatty Liver Disease

Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

Abstract 2472: Mechanisms of resistance to IGFR-targeted therapy in pediatric sarcomas

Abstract 286: Preclinical study: HDAC inhibition combined with gemcitabine for the treatment of leiomyosarcoma

Abstract LB-014: Targeting insulin receptor splicing as a therapeutic intervention for pediatric rhabdomyosarcoma

ET-59DEVELOPMENT AND CHARACTERIZATION OF A MEK1 INHIBITOR (AZD6244) SENSITIVE CHILDHOOD ASTROCYTOMA CELL LINE

Abstract B40: Autocrine and paracrine IL-6 and IL-8 drive osteosarcoma lung tropism and facilitate metastasis

Abstract A45: Autocrine and paracrine IL-6 and IL-8 drive osteosarcoma metastasis

Abstract 25: Targeting c-Myc in pediatric sarcoma xenografts with the BET bromodomain inhibitor, JQ1, disrupts angiogenesis

Abstract 2775: Development and characterization of a MEK1 inhibitor (AZD6244) sensitive childhood astrocytoma cell line

Corrigendum to “Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents” [Bioorg. Med. Chem. 19 (2011) 5409–5419]

ET-59 DEVELOPMENT AND CHARACTERIZATION OF A MEK1 INHIBITOR (AZD6244) SENSITIVE CHILDHOOD ASTROCYTOMA CELL LINE

Aktive Filter

Suchergebnisse filtern